Income Tax Expense (Benefit) of Organon & Co. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Organon & Co. quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Organon & Co. Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $83,000,000.
  • Organon & Co. Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $201,000,000.
  • Organon & Co. annual Income Tax Expense (Benefit) for 2024 was $57,000,000, a 84% increase from 2023.
  • Organon & Co. annual Income Tax Expense (Benefit) for 2023 was $350,000,000, a 271% decline from 2022.
  • Organon & Co. annual Income Tax Expense (Benefit) for 2022 was $205,000,000, a 15% increase from 2021.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

Organon & Co. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $201,000,000 $83,000,000 +$235,000,000 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $34,000,000 $84,000,000 +$44,000,000 +110% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $78,000,000 $14,000,000 -$21,000,000 -60% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q4 2024 $57,000,000 $20,000,000 +$462,000,000 01 Oct 2024 31 Dec 2024 10-K/A 10 Nov 2025 2024 FY
Q3 2024 $519,000,000 $152,000,000 -$174,000,000 -791% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025 2025 Q3
Q2 2024 $345,000,000 $40,000,000 +$28,000,000 +233% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $373,000,000 $35,000,000 -$23,000,000 -40% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q4 2023 $350,000,000 $442,000,000 -$445,000,000 -14833% 01 Oct 2023 31 Dec 2023 10-K/A 10 Nov 2025 2024 FY
Q3 2023 $95,000,000 $22,000,000 -$33,000,000 -60% 01 Jul 2023 30 Sep 2023 10-Q 01 Nov 2024 2024 Q3
Q2 2023 $128,000,000 $12,000,000 -$41,000,000 -77% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $169,000,000 $58,000,000 -$36,000,000 -38% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q4 2022 $205,000,000 $3,000,000 -$31,000,000 -91% 01 Oct 2022 31 Dec 2022 10-K/A 10 Nov 2025 2024 FY
Q3 2022 $236,000,000 $55,000,000 -$11,000,000 -17% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $247,000,000 $53,000,000 +$47,000,000 +783% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $200,000,000 $94,000,000 +$22,000,000 +31% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q4 2021 $178,000,000 $34,000,000 -$115,000,000 -77% 01 Oct 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
Q3 2021 $293,000,000 $66,000,000 -$55,000,000 -45% 01 Jul 2021 30 Sep 2021 10-Q 04 Nov 2022 2022 Q3
Q2 2021 $348,000,000 $6,000,000 -$110,000,000 -95% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2021 $458,000,000 $72,000,000 -$38,000,000 -35% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q4 2020 $496,000,000 $149,000,000 01 Oct 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
Q3 2020 $121,000,000 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $116,000,000 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $110,000,000 01 Jan 2020 31 Mar 2020 10-Q 21 Jun 2021 2021 Q1

Organon & Co. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $57,000,000 +$293,000,000 +84% 01 Jan 2024 31 Dec 2024 10-K/A 10 Nov 2025 2024 FY
2023 $350,000,000 -$555,000,000 -271% 01 Jan 2023 31 Dec 2023 10-K/A 10 Nov 2025 2024 FY
2022 $205,000,000 +$27,000,000 +15% 01 Jan 2022 31 Dec 2022 10-K/A 10 Nov 2025 2024 FY
2021 $178,000,000 -$318,000,000 -64% 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
2020 $496,000,000 +$106,000,000 +27% 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023 2022 FY
2019 $390,000,000 01 Jan 2019 31 Dec 2019 10-K 21 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.